Subject
Health Policy,Biomedical Engineering
Reference43 articles.
1. Measuring performance in off-patent drug markets: a methodological framework and empirical evidence from twelve EU Member States;Kanavos;Health Policy,2014
2. The intensity of competition after patent expiry in pharmaceuticals. A cross-country analysis;Pammolli;Revue d'économie industrielle,2002
3. Comparing generic drug markets in Europe and the United States: prices, volumes, and spending;Wouters;Milbank Q.,2017
4. Buehler, G., & Director, A. D. (2010). History of bioequivalence for critical dose drugs. US Food and Drug Administrations hemsida [www]. Hämtat från: http://www.fda.gov [uppdaterad 2010-04-13, citerad 2014-03-15].
5. The new European Medicines Agency guideline on the investigation of bioequivalence;Morais;Basic Clin. Pharmacol. Toxicol.,2010
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献